Novartis AG ADR (NYSE: NVS) kicked off on Friday, down -0.49% from the previous trading day, before settling in for the closing price of $131.91. Over the past 52 weeks, NVS has traded in a range of $96.06-$134.00.
A company in the Healthcare sector has jumped its sales by 13.96% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 14.39%. With a float of $1.90 billion, this company’s outstanding shares have now reached $1.92 billion.
Novartis AG ADR (NVS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Novartis AG ADR is 0.01%, while institutional ownership is 7.14%. The most recent insider transaction that took place on May 23 ’25, was worth 1,690,181. Before that another transaction happened on Apr 30 ’25, when Company’s Officer proposed sale 1,212 for $113.28, making the entire transaction worth $137,297.
Novartis AG ADR (NVS) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported 1.98 earnings per share (EPS), higher than consensus estimate (set at 1.76) by 0.22.
According to the Wall Street analysts, stocks earnings will be around 14.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.05% during the next five years compared to 13.96% growth over the previous five years of trading.
Novartis AG ADR (NYSE: NVS) Trading Performance Indicators
Take a look at Novartis AG ADR’s (NVS) current performance indicators. Last quarter, stock had a quick ratio of 0.68. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.57. Likewise, its price to free cash flow for the trailing twelve months is 12.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.33, a number that is poised to hit 1.97 in the next quarter and is forecasted to reach 9.17 in one year’s time.
Technical Analysis of Novartis AG ADR (NVS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.51 million. That was inferior than the volume of 1.83 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 85.01%.
During the past 100 days, Novartis AG ADR’s (NVS) raw stochastic average was set at 87.35%, which indicates a significant increase from 77.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.69 in the past 14 days, which was higher than the 1.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $127.56, while its 200-day Moving Average is $117.76. However, in the short run, Novartis AG ADR’s stock first resistance to watch stands at $132.58. Second resistance stands at $133.90. The third major resistance level sits at $135.04. If the price goes on to break the first support level at $130.12, it is likely to go to the next support level at $128.98. Assuming the price breaks the second support level, the third support level stands at $127.66.
Novartis AG ADR (NYSE: NVS) Key Stats
The company with the Market Capitalisation of 249.08 billion has total of 2,112,422K Shares Outstanding. Its annual sales at the moment are 51,722 M in contrast with the sum of 11,941 M annual income. Company’s last quarter sales were recorded 14,358 M and last quarter income was 3,928 M.
